References
- Albright AL, Cervi A. Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. Journal of the American Medical Association 1991; 265: 1418–1422
- Albright AL, Barry MJ, Fasick MP, Janosky J. Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity. Pediatric Neurosurgery 1995; 23: 82–85
- Gilmartin R, Bruce D, Storrs BB, Abbott R, Krach L, Ward J, Bloom K, Brooks WH, Johnson DL, Madsen JR. Intrathecal baclofen for management of spastic cerebral palsyMulticenter trial . Journal of Child Neurology 2000; 15: 71–77
- Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. Journal of Neurosurgery 2003; 98: 291–295
- Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R. Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. Journal of Child Neurology 2003; 18: 26–34
- Sampson FC, Hayward A, Evans G, Morton R, Collett B. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. The Journal of Neurosurgery 2002; 96: 1052–1057
- Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity. A clinical survey. American Journal of Physical Medicine and Rehabilitation 2000; 79: 536–541
- Staal C, Arends A, Ho S. A self-report of quality of life of patients receiving intrathecal baclofen therapy. Rehabilitation Nursing 2003; 28: 159–163
- Msall ME, Tremont MR, Lyon N. 1998, Amount of assistance questionnaire-long form, Version 2.0, 1 October
- Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Care provider assessment of intrathecal baclofen in children. Developmental Medicine and Child Neurology 2004; 46: 548–552
- Campbell WM, Ferrel A, McLaughlin JF, Grant GA, Loeser JD, Graubert C, Bjornson K. Long-term safety and efficacy of continuous intrathecal baclofen. Developmental Medicine and Child Neurology 2002; 44: 660–665
- Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. Journal of Neurosurgery 1997; 87: 409–414
- Kofler M, Matzak H, Saltuari L. The impact of intrathecal balcofen on gastrointestinal function. Brain Injury 2002; 16: 825–836
- Al-Khodairy AT, Vuagnat H, Uebelhart D. Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure: A case report. American Journal of Physical Medicine and Rehabilitation 1999; 78: 272–277
- Dickerman RD, Schneider SJ. Recurrent intrathecal baclofen pump catheter leakage: A surgical observation with recommendations. Journal of Pediatric Surgery 2002; 37: 17–19
- Dickerman RD, Stevens QE, Schneider SJ. The role of surgical placement and pump orientation in intrathecal pump system failure. A technical report. Pediatric Neurosurgery 2003; 38: 107–109
- Dawes WJ, Drake JM, Fehlings D. Microfracture of a baclofen pump catheter with intermittent under- and overdose. Pediatric Neurosurgery 2003; 39: 144–148
- Bardutzky J, Tronnier V, Schwab S, Meinck H-M. Intrathecal baclofen for stiff-person syndrome: Life-threatening intermittent catheter leakage. Neurology 2003; 60: 1976–1978
- Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. New England Journal of Medicine 2004; 351: 575–584
- Epstein AM. Heath care in America—still too separate, not yet equal. New England Journal of Medicine 2004; 351: 603–605